Adagene (ADAG)
(Delayed Data from NSDQ)
$2.37 USD
+0.47 (24.79%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $2.43 +0.06 (2.53%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Adagene Inc. Sponsored ADR's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ADAG 2.37 +0.47(24.79%)
Will ADAG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ADAG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADAG
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
ADAG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Bioventus (BVS) Outperforming Other Medical Stocks This Year?
Are Medical Stocks Lagging Adagene (ADAG) This Year?
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
Other News for ADAG
Adagene (ADAG) Coverage Initiated by Leerink Partners with $7 PT | ADAG Stock News
This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Adagene (ADAG) Receives Outperform Rating from Leerink
Adagene initiated with bullish view at Leerink, here's why
Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in ...